Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora

Published:2023-04 Issue: Volume:371 Page:32-40
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Hao Han,Li Zhu,Qiao Shi-yang,Qi Yu,Xu Xiao-ying,Si Jia-yi,Liu Yi-hai,Chang Lei,Shi Yi-fan,Xu Biao,Wei Zhong-hai,Kang Li-na

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference48 articles.

1. Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice;Pennig;Sci. Rep.,2019

2. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE (-/-) mice fed a western diet;Han;Diabetologia,2017

3. Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity;Liu;Lipids Health Dis.,2021

4. Role of gut microbiota in atherosclerosis;Jonsson;Nat. Rev. Cardiol.,2017

5. In silico analyses of metagenomes from human atherosclerotic plaque samples;Mitra;Microbiome,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE−/− Mice;Cell Biochemistry and Biophysics;2024-08-22

2. Gut microbiota as a residual risk factor causally influencing cardiac structure and function: Mendelian randomization analysis and biological annotation;Frontiers in Microbiology;2024-07-26

3. The current landscape for diabetes treatment: Preventing diabetes-associated CV risk;Atherosclerosis;2024-07

4. Research progress of Ganoderma lucidum polysaccharide in prevention and treatment of Atherosclerosis;Heliyon;2024-06

5. Protective Mechanisms of SGLTi in Ischemic Heart Disease;Journal of Cardiovascular Translational Research;2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3